Because some patients in this study had previously been screened for the common variants in COL1A1/COL1A2 at other hospitals, our OI cohort included a high proportion of patients with non-type I collagen variants and rare pathogenic variants. This evidence concerns the gene COL1A2 and osteogenesis imperfecta.